These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28617073)

  • 1. Metabolomics of exhaled breath condensate: a means for phenotyping respiratory diseases?
    Maniscalco M; Motta A
    Biomark Med; 2017 May; 11(6):405-407. PubMed ID: 28617073
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases.
    Maniscalco M; Fuschillo S; Paris D; Cutignano A; Sanduzzi A; Motta A
    Adv Clin Chem; 2019; 88():121-149. PubMed ID: 30612604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled biomarkers.
    Kharitonov SA; Barnes PJ
    Chest; 2006 Nov; 130(5):1541-6. PubMed ID: 17099035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study.
    Maniscalco M; Paris D; Melck DJ; Molino A; Carone M; Ruggeri P; Caramori G; Motta A
    Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29348154
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomarkers in exhaled breath condensate as fingerprints of asthma, chronic obstructive pulmonary disease and asthma-chronic obstructive pulmonary disease overlap: a critical review.
    Seyfinejad B; Nemutlu E; Taghizadieh A; Khoubnasabjafari M; Ozkan SA; Jouyban A
    Biomark Med; 2023 Oct; 17(19):811-837. PubMed ID: 38179966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study.
    Antus B; Barta I; Kullmann T; Lazar Z; Valyon M; Horvath I; Csiszer E
    Am J Respir Crit Care Med; 2010 Dec; 182(12):1492-7. PubMed ID: 20656939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics of Respiratory Diseases.
    Moitra S; Bandyopadhyay A; Lacy P
    Handb Exp Pharmacol; 2023; 277():339-365. PubMed ID: 36306009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences of inflammatory mechanisms in asthma and COPD.
    Ichinose M
    Allergol Int; 2009 Sep; 58(3):307-13. PubMed ID: 19628975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease.
    Santini G; Mores N; Penas A; Capuano R; Mondino C; Trové A; Macagno F; Zini G; Cattani P; Martinelli E; Motta A; Macis G; Ciabattoni G; Montuschi P
    Curr Top Med Chem; 2016; 16(14):1610-30. PubMed ID: 26693732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics.
    Kilk K; Aug A; Ottas A; Soomets U; Altraja S; Altraja A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells in asthma and COPD: opportunities for drug development.
    Kool M; Lambrecht BN
    Curr Opin Immunol; 2007 Dec; 19(6):701-10. PubMed ID: 17977704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Potential Role of Metabolomics in COPD: A Concise Review.
    Tirelli C; Mira S; Belmonte LA; De Filippi F; De Grassi M; Italia M; Maggioni S; Guido G; Mondoni M; Canonica GW; Centanni S
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen peroxide content and pH of expired breath condensate from patients with asthma and COPD.
    Murata K; Fujimoto K; Kitaguchi Y; Horiuchi T; Kubo K; Honda T
    COPD; 2014 Feb; 11(1):81-7. PubMed ID: 24111595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of exhaled particles from the human lungs in airway obstruction.
    Schwarz K; Biller H; Windt H; Koch W; Hohlfeld JM
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):52-8. PubMed ID: 24914577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled breath condensate biomarkers in COPD.
    Borrill ZL; Roy K; Singh D
    Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pH of the exhaled breath condensate: new method for investigation of inflammatory airway diseases].
    Szili B; Bikov A; Kollai M; Horváth I
    Orv Hetil; 2007 Jul; 148(26):1217-24. PubMed ID: 17588855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
    Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
    Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma.
    Pappas K; Papaioannou AI; Kostikas K; Tzanakis N
    Cytokine; 2013 Dec; 64(3):613-25. PubMed ID: 24084332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in IL-8 in serum and exhaled breath condensate from patients with exacerbated COPD or asthma attacks.
    Liu HC; Lu MC; Lin YC; Wu TC; Hsu JY; Jan MS; Chen CM
    J Formos Med Assoc; 2014 Dec; 113(12):908-14. PubMed ID: 25530067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of biomarkers in COPD by metabolomics of exhaled breath condensate and serum/plasma.
    Paris D; Palomba L; Tramice A; Motta L; Fuschillo S; Maniscalco M; Motta A
    Minerva Med; 2022 Jun; 113(3):424-435. PubMed ID: 35191295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.